Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member: free to download

Volume:16   Issue: 3
Pp: 199-199
Ingunn Holen
DOI: 10.2174/156800961603160206121939
Published on: 06 February, 2016

Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy

Volume:16   Issue: 3
Pp: 200-208
Martin Andrs, Jan Korabecny, Eugenie Nepovimova, Daniel Jun, Zdenek Hodny and Kamil Kuca
DOI: 10.2174/156800961603160206122927
Published on: 06 February, 2016


Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?

Volume:16   Issue: 3
Pp: 209-214
Giandomenico Roviello and Daniele Generali
DOI: 10.2174/1568009616666151106120716
Published on: 06 February, 2016

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

Volume:16   Issue: 3
Pp: 215-225
Rashi Arora, Sharad Sawney and Daman Saluja
DOI: 10.2174/1568009616666151113120146
Published on: 06 February, 2016


Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models

Volume:16   Issue: 3
Pp: 226-237
Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos
DOI: 10.2174/1568009616666151113120705
Published on: 06 February, 2016


Role of Liprins in the Regulation of Tumor Cell Motility and Invasion

Volume:16   Issue: 3
Pp: 238-248
Sara Chiaretti and Ivan de Curtis
DOI: 10.2174/156800961603160206124103
Published on: 06 February, 2016


Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer

Volume:16   Issue: 3
Pp: 249-260
A. Nogueira-Rodrigues, A.C. Melo, G. Werutsky, A.H.I. Garces and C.G. Ferreira
DOI: 10.2174/1568009616666151118115018
Published on: 06 February, 2016

Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

Volume:16   Issue: 3
Pp: 261-274
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra
DOI: 10.2174/1568009616666151106120434
Published on: 06 February, 2016


The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

Volume:16   Issue: 3
Pp: 275-286
Jui-Ling Tsai, Yu-May Lee, Chien-Yuan Pan and Alan Yueh-Luen Lee
DOI: 10.2174/156800961603160206125352
Published on: 06 February, 2016